155 related articles for article (PubMed ID: 16676274)
1. [Risk factors associated to the presentation of episodes of major depression in a population of outpatients with Parkinson's disease].
Chaná-Cuevas P; Juri-Claverías C; Alburquerque D; Soto-Olmedo MJ; Benavides-Canales O
Rev Neurol; 2006 May 1-15; 42(9):521-4. PubMed ID: 16676274
[TBL] [Abstract][Full Text] [Related]
2. Depression and major depressive disorder in patients with Parkinson's disease.
Inoue T; Kitagawa M; Tanaka T; Nakagawa S; Koyama T
Mov Disord; 2010 Jan; 25(1):44-9. PubMed ID: 20014057
[TBL] [Abstract][Full Text] [Related]
3. Depressive illness in Parkinson's disease--indication of a more advanced and widespread neurodegenerative process?
Pålhagen SE; Carlsson M; Curman E; Wålinder J; Granérus AK
Acta Neurol Scand; 2008 May; 117(5):295-304. PubMed ID: 18279483
[TBL] [Abstract][Full Text] [Related]
4. Application of depression criteria (DSM-IV) in patients with Parkinson's disease.
Gómez-Esteban JC; Tijero B; Somme J; Bilbao I; Fernández J; Boyero S; Velasco F; Lezcano E; Zarranz JJ
Clin Neurol Neurosurg; 2009 Oct; 111(8):665-9. PubMed ID: 19589638
[TBL] [Abstract][Full Text] [Related]
5. The Unified Parkinson's Disease Rating Scale: validation study of the mentation, behavior, and mood section.
Starkstein SE; Merello M
Mov Disord; 2007 Nov; 22(15):2156-61. PubMed ID: 17721877
[TBL] [Abstract][Full Text] [Related]
6. [Neuropsychiatric problems in patients with Parkinson's disease].
Zhou MZ; Liu ZG; Gan J; Chen W; Lu LX; Wu JY
Zhonghua Yi Xue Za Zhi; 2008 Jun; 88(21):1442-5. PubMed ID: 18953846
[TBL] [Abstract][Full Text] [Related]
7. [Rasagiline in daily clinical use. Results of a treatment study of Parkinson patients with a combination treatment].
Jost WH; Klasser M; Reichmann H
Fortschr Neurol Psychiatr; 2008 Oct; 76(10):594-9. PubMed ID: 18833504
[TBL] [Abstract][Full Text] [Related]
8. [Risk factors associated with the development of motor complications in Parkinson's disease. A study in a Chilean population].
Juri-Claveria C; Aguirre-M C; Viviani-G P; Chana-Cuevas P
Rev Neurol; 2007 Jul 16-31; 45(2):77-80. PubMed ID: 17642046
[TBL] [Abstract][Full Text] [Related]
9. Anxiety disorders in Parkinson's disease: prevalence and risk factors.
Dissanayaka NN; Sellbach A; Matheson S; O'Sullivan JD; Silburn PA; Byrne GJ; Marsh R; Mellick GD
Mov Disord; 2010 May; 25(7):838-45. PubMed ID: 20461800
[TBL] [Abstract][Full Text] [Related]
10. [Physical symptoms of Parkinson's disease and the score on Beck's Depression Inventory].
Emanuels-Zuurveen ES; Brouwer WH; Lakke JP; Bouhuys AL
Tijdschr Gerontol Geriatr; 1991 Aug; 22(4):134-8. PubMed ID: 1926297
[TBL] [Abstract][Full Text] [Related]
11. Depression in Parkinson's disease: a double-blind, randomized, placebo-controlled pilot study of omega-3 fatty-acid supplementation.
da Silva TM; Munhoz RP; Alvarez C; Naliwaiko K; Kiss A; Andreatini R; Ferraz AC
J Affect Disord; 2008 Dec; 111(2-3):351-9. PubMed ID: 18485485
[TBL] [Abstract][Full Text] [Related]
12. Depressive symptoms in Parkinson disease correlate with impaired global and specific cognitive performance.
Fernandez HH; See RH; Gary MF; Bowers D; Rodriguez RL; Jacobson C; Okun MS
J Geriatr Psychiatry Neurol; 2009 Dec; 22(4):223-7. PubMed ID: 19429848
[TBL] [Abstract][Full Text] [Related]
13. Epidemiology of major depression in Belgian parkinsonian patients.
Vanderheyden JE; Gonce M; Bourgeois P; Cras P; De Nayer AR; Flamez A; Supiot F; Donneau AF; Albert A; Berlaimont V;
Acta Neurol Belg; 2010 Jun; 110(2):148-56. PubMed ID: 20873444
[TBL] [Abstract][Full Text] [Related]
14. Long-term effect of initiating pramipexole vs levodopa in early Parkinson disease.
Parkinson Study Group CALM Cohort Investigators
Arch Neurol; 2009 May; 66(5):563-70. PubMed ID: 19433655
[TBL] [Abstract][Full Text] [Related]
15. Factors affecting the quality of life of patients with idiopathic Parkinson's disease--a cross-sectional study in an outpatient clinic attendees.
Sławek J; Derejko M; Lass P
Parkinsonism Relat Disord; 2005 Nov; 11(7):465-8. PubMed ID: 16154794
[TBL] [Abstract][Full Text] [Related]
16. [Evaluation of cognitive impairment in a population of patients with Parkinson's disease by means of the mini mental Parkinson test].
Parrao-Díaz T; Chaná-Cuevas P; Juri-Claverías C; Kunstmann C; Tapia-Núñez J
Rev Neurol; 2005 Mar 16-31; 40(6):339-44. PubMed ID: 15795869
[TBL] [Abstract][Full Text] [Related]
17. Depression in patients with Parkinson's disease: impact on functioning.
Stella F; Banzato CE; Barasnevicius Quagliato EM; Viana MA
J Neurol Sci; 2008 Sep; 272(1-2):158-63. PubMed ID: 18589453
[TBL] [Abstract][Full Text] [Related]
18. Vulnerability to emotionally negative stimuli in Parkinson's disease: an investigation using the Emotional Stroop task.
Serra-Mestres J; Ring HA
Neuropsychiatry Neuropsychol Behav Neurol; 1999 Jan; 12(1):52-7. PubMed ID: 10082333
[TBL] [Abstract][Full Text] [Related]
19. Psychometric properties of the Parkinson's Disease Sleep Scale--Brazilian version.
Margis R; Donis K; Schönwald SV; Fagondes SC; Monte T; Martín-Martínez P; Chaudhuri KR; Kapczinski F; Rieder CR
Parkinsonism Relat Disord; 2009 Aug; 15(7):495-9. PubMed ID: 19211294
[TBL] [Abstract][Full Text] [Related]
20. Prevalence and clinical correlates of apathy in Parkinson's disease: a community-based study.
Pedersen KF; Larsen JP; Alves G; Aarsland D
Parkinsonism Relat Disord; 2009 May; 15(4):295-9. PubMed ID: 18801696
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
